Peptide Based Vaccine Approaches for Cancer—A Novel Approach Using a WT-1 Synthetic Long Peptide and the IRX-2 Immunomodulatory Regimen

Peptide Based Vaccine Approaches for Cancer—A Novel Approach Using a WT-1 Synthetic Long Peptide and the IRX-2 Immunomodulatory Regimen

Therapeutic cancer vaccines have the potential to generate a long lasting immune response that will destroy tumor cells with specificity and safety, in contrast to many other current cancer therapies. Clinical success to date has been limited by a number of factors including choice of immunogenic ca...

Full description

Bibliographic Details
Main Authors: James E. Egan, Paul H. Naylor, Neil L. Berinstein
Format: Article
Language:English
Published: MDPI AG 2011-10-01
Series:Cancers
Subjects:
IRX-2
synthetic long peptides
Wilms’ tumor gene 1
WT-1
cancer vaccine
immunomodulator
adjuvant
Online Access:http://www.mdpi.com/2072-6694/3/4/3991/

Internet

http://www.mdpi.com/2072-6694/3/4/3991/

Similar Items